Beta glycosphingolipids suppress rank expression and inhibit natural killer T cell and CD8+ accumulation in alleviating aortic valve calcification

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 4, 2009, Pages 911-918

  Shuvy, M ^a   Ben Ya'Acov, A ^a   Zolltarov, L ^a   Lotan, C ^a   Ilan, Yaron ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Aortic valve; Calcification; Glycosphingolipids; Nkt cells

Indexed keywords

ADENINE; BETA GLUCOSYLCERAMIDE; BETA LACTOSYLCERAMIDE; ELECTROLYTE; GLYCOSPHINGOLIPID; PHOSPHORUS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA VALVE; AORTA VALVE CALCIFICATION; APOPTOSIS; ARTERY CALCIFICATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 76349101869     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200406     Document Type: Article

References (25)

1. Aronow WS. Valvular aortic stenosis in the elderly. Cardiol Rev 2007; 15:217-25.
2. Carabello BA. Aortic stenosis: from pressure overload to heart failure. Heart Fail Clin 2006; 2: 435-42.
3. Hara H, Pedersen WR, Ladich E, Mooney M, Virmani R, Nakamura M, Feldman T, Schwartz RS. Percutaneous balloon aortic valvuloplasty revisited: time for a renaissance? Circulation 2007; 115: 334-8.
4. Cohn LH, Narayanasamy N. Aortic valve replacement in elderly patients: what are the limits? Curr Opin Cardiol 2007; 22;92-5.
5. Leon MB, Kodali S, Williams M, Oz M, Smith C, Stewart A, Schwartz A, Collins M, Moses JW Transcatheter aortic valve replacement in patients with critical aortic stenosis: rationale, device descriptions, early clinical experiences, and perspectives. Semin Thorac Cardiovasc Surg 2006; 18:165-74.
6. O'Brien KD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 2006; 26: 1721-28.
7. Wu XB, Li Y, Schneider A, et al. Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest 2003; 112:924-34.
8. Hamdy NA. Targeting the RANK/RANKL/OPG signaling pathway: a novel approach in the management of osteoporosis. Curr Opin Investig Drugs 2007; 8:299-303.
9. Kaden JJ, Bickelhaupt S, Grobholz R, et al. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol 2004; 36:57-66
10. Shetty R, Pepin A, Charest A, Perron J, Doyle D, Voisine P, Dagenais F, Pibarot P, Mathieu P. Expression of bone-regulatory proteins in human valve allografts. Heart 2006; 92:1303-8.
11. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999; 402:304-9.
12. Wallby L, Steffensen T, Broqvist M. Role of inflammation in non-rheumatic, regurgitant heart valve disease. A comparative, descriptive study regarding apolipoproteins and inflammatory cells in non-rheumatic heart valve disease. Cardiovasc Pathol 2007; 16:171-8.
13. Lalazar G, Preston S, Zigmond E, Ben Yaacov A, Ilan Y. Glycolipids as immune modulatory tools. Mini Rev Med Chem 2006; 6:1249-53.
14. Safadi R, Zigmond E, Pappo O, Shalev Z, Ilan Y. Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. Int Immunol 2007; 19:1021-29.
15. Zigmond E, Preston S, Pappo O, et al. Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders. Gut 2007; 56:82-9.
16. Ilan Y, Ohana M, Pappo O, Margalit M, Lalazar G, Engelhardt D, Rabbani E, Nagler A. Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity. Transplantation 2007; 83:458-67.
17. Trop S, Samsonov D, Gotsman I, Alper R, Diment J, Ilan Y. Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model. Hepatology 1999; 29: 746-55.
18. Shibolet O, Alper R, Avraham Y, Berry EM, Ilan Y. Immunomodulation of experimental colitis via caloric restriction: role of Nk1.1+ T cells. Clin Immunol 2002; 105:48-56.
19. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15:827-32.
20. Shuvy M, Abedat S, Beeri R, et al. Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats. Cardiovasc Res 2008; 79:492-9.
21. Wallby L, Janerot-Sjoberg B, Steffensen T, Broqvist M. T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves. Heart 2002; 88: 348-51.
22. Wu HD, Maurer MS, Friedman RA, et al. The lymphocytic infiltration in calcific aortic stenosis predominantly consists of clonally expanded T cells. J Immunol 2007; 178:5329-39.
23. Legare JF, Lee TD, Creaser K, Ross DB. T lymphocytes mediate leaflet destruction and allograft aortic valve failure in rats. Ann Thorac Surg 2000; 70:1238-45.
24. Clarke MC, Littlewood TD, Figg N, Maguire JJ, Davenport AP, Goddard M, Bennett MR. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 2008; 102:1529-38.
25. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000; 87:1055-62.